PMID: 25796774Mar 24, 2015Paper

Depression and type 2 diabetes: etiopathogenic analysis of a frequent comorbidity

Revue médicale de Liège
D LuppensW Pitchot

Abstract

Recent advances in the neurobiology of depression have underlined the importance of markers of inflammation, neurotrophins, and hypothalamo-pituitary adrenal (HPA) axis dysfunction in the development of this pathology. These disorders could have some impact on other systems such as the glucose metabolism regulation with an increased risk of insulin resistance and type 2 diabetes. Type 2 diabetes is also frequently associated with a pro-inflammatory state that could favour the development of a depressive episode. Inflammatory phenomena and HPA axis dysfunction could be biological links between depression and type 2 diabetes and account not only for the frequent association between those two disorders, but also for the treatment-resistance to classical antidepressants.

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Horumon to rinsho. Clinical endocrinology
T OnishiY Kumahara
Current Topics in Medicinal Chemistry
Brian Dyck
The New England Journal of Medicine
© 2021 Meta ULC. All rights reserved